Look into supporting mitochondria health [0] and the glymphatic system [1]: good diet (with fasting), light to moderate exercise, sleep and wake at the same time each day for circadian rhythm training, reduce unnecessary stress.
Once the basics have been implemented, some supplements could help to further support cell function if needed: Longevity supplements that Dr David Sinclair takes [2], boosting cellular glutathione stores, with NACET, glycine, selenium [3]
[0] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684129/ [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698404/ [2] https://novoslabs.com/best-anti-aging-supplements-that-harva... [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889054/
One nurse once told me that there's a connection between the decline and another medication - one for reflux, pantoprazol or so.
If the connection is via diabetes, a low carb/no carb diet might help - if someone else is cooking the food that should be easy. God's speed!
Interesting to find out it has it's own wiki page
https://www.virtahealth.com/research
It's unknown whether that would reduce the risk of Alzheimer's disease. Worth a try anyways.
EMPHASIS: 1972! 50 years ago.
And processed foods is everywhere. And people are wondering why we have diabetes and possibly brain diabetes that is Alzheimer's.
Sugar.
I think the correlation is more so to sugar.
I too had a loved one with Alzheimer’s, and there was definitely strong reason to believe sugar was a contributing factor.
I believe there are quite a few scientists that agree with you. Some are trying to rename Alzheimer's to Type-3 diabetes. There are some articles sprinkled throughout nih.gov PubMed on this topic.
In the past I have eaten a fruitarian diet to fuel my workouts. And sometimes I consumed pure sugar.
... just kidding they all work together
> The most influential Cassava-related paper appeared in The Journal of Clinical Investigation in 2012. The authors—including Wang; Arnold; David Bennett, who leads a brain-tissue bank at Rush University; and his Rush colleague, neuroscientist Zoe Arvanitakis—linked insulin resistance to Alzheimer’s and the formation of amyloid plaques. Cassava scientists say Simufilam lessens insulin resistance. They relied on a method in which dead brain tissue, frozen for a decade and then partially thawed and chopped, purportedly generates chemical signals.
> Schrag and others say it contradicts basic neurobiology. Schrag adds that he could find no evidence that other investigators have replicated that result. (None of the authors agreed to be interviewed for this article.)
> That paper supported the science behind Simufilam, Schrag says, “and spawned an entire field of research in Alzheimer’s, ‘diabetes of the brain.’” It has been cited more than 1500 times. Schrag sent the journal’s editor his analysis of more than 15 suspect images in two groups. The editor says the journal analyzed high-resolution versions of the images in the first group. It could not corroborate his findings and therefore did not investigate further.
>Overall, a growing body of evidence supports the nine potentially modifiable risk factors for dementia modelled by the 2017 Lancet Commission on dementia prevention, intervention, and care: less education, hypertension, hearing impairment, smoking, obesity, depression, physical inactivity, diabetes, and low social contact.
[0] Full report from July 2020 issue of The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
https://www.alz.org/media/Documents/alzheimers-dementia-diab...
One area I'm particularly interested in is the correlation to diabetes. It's a factor that I found being mentioned here and there in some references. In the immediate case that interests me, there's a 20+ year history of type 2 diabetes and a recent scan showed severe bilateral hypocampal atrophy. When googling for a link between the two I found this: "Lower insulin secretion was significantly associated with HPGA (hippocampal and parahippocampal gyrus atrophy) in patients with type 2 diabetes mellitus. The results of this study support the hypothesis that insulin‐signaling abnormalities are involved in the pathophysiology of Alzheimer’s disease." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504906/
Yet, the mechanism of this, if indeed there's causality (not just correlation) does not seem to be known.